In Silico Identification of Widely Used and Well Tolerated Drugs That May Inhibit SARSCov- 2 3c-Like Protease and Viral RNA-Dependent RNA Polymerase Activities, and May Have Potential to Be Directly Used in Clinical Trials

doi 10.26434/chemrxiv.12123204